Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

SpringerPlus

Table 1 Chemotherapy regimens, dosages, post-cooling times and number of patients who finished the DigniCap evaluation

Chemotherapy regimen and doses	No of patients	Post-cooling time (min)
(Neo-)adjuvant CT
E₉₀C₆₀₀ (q3w4) - > Doc_100/175 (q3w4)¹	32	100
F₅₀₀E₁₀₀C₅₀₀ (q3w*6)	15	120
F₅₀₀E₁₀₀C₅₀₀ (q3w3) - > Doc₁₀₀ (q3w3)	7	120 - > 100
E₉₀C₆₀₀ (q3w*4)	3	100
CarboPt/Doc (q3w*6)	1	90
Palliative CT
Taxol₁₃₅/Herceptin_8mg/kg	1	90
Halaven_1.23	1	120
Taxol₉₀/Avastin_10mg/kg	3	60
Carboplatin	1	90
Gemcitabine/Cisplatin	(1²)	60

¹Three patients were included receiving three-weekly (neo-)adjuvant Doc/EC. Of them, one patient was treated with Doc₁₇₅ and two with Doc₁₀₀.
²One patient finished an adjuvant CT (EC/Doc) before a palliative treatment (three cycles Carboplatin followed by two cycles Gemcitabine/Cisplatin) was started.